Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Mehta

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Lancet (London, England)|June 10, 2017
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trialsKristian Reich, Kim A Papp, Andrew Blauvelt, et al.
Journal of Clinical Pharmacology|June 5, 2014
Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs - midazolam and odanacatibEugene E Marcantonio, Jeanine Ballard, Christopher R Gibson, et al.
Circulation. Arrhythmia and Electrophysiology|October 13, 2012
MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humansBehzad B Pavri, Howard E Greenberg, Walter K Kraft, et al.
Clinical Parkinsonism & Related Disorders|January 6, 2025
Assessment of social isolation and changes in Parkinson's disease symptoms during the COVID-19 pandemic: A longitudinal studyAnish Mehta, Samuel Y E Ng, Shermyn X M Neo, et al.
Nature|March 11, 2015
Clinical improvement in psoriasis with specific targeting of interleukin-23Tamara Kopp, Elisabeth Riedl, Christine Bangert, et al.
Plos One|June 26, 2025
Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented populationRavi Yadav, Saikat Dey, Ravichandiran Kumar, et al.
Current Medical Research and Opinion|August 19, 2014
Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trialMyung Chul Yoo, Wan Hee Yoo, Seung Baek Kang, et al.
Circulation. Heart Failure|October 30, 2019
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical CenterLauren A Eberly, Aaron Richterman, Anne G Beckett, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Lancet (London, England)|June 10, 2017
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trialsKristian Reich, Kim A Papp, Andrew Blauvelt, et al.
Journal of Clinical Pharmacology|June 5, 2014
Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs - midazolam and odanacatibEugene E Marcantonio, Jeanine Ballard, Christopher R Gibson, et al.
Circulation. Arrhythmia and Electrophysiology|October 13, 2012
MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humansBehzad B Pavri, Howard E Greenberg, Walter K Kraft, et al.
Clinical Parkinsonism & Related Disorders|January 6, 2025
Assessment of social isolation and changes in Parkinson's disease symptoms during the COVID-19 pandemic: A longitudinal studyAnish Mehta, Samuel Y E Ng, Shermyn X M Neo, et al.
Nature|March 11, 2015
Clinical improvement in psoriasis with specific targeting of interleukin-23Tamara Kopp, Elisabeth Riedl, Christine Bangert, et al.
Plos One|June 26, 2025
Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented populationRavi Yadav, Saikat Dey, Ravichandiran Kumar, et al.
Current Medical Research and Opinion|August 19, 2014
Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trialMyung Chul Yoo, Wan Hee Yoo, Seung Baek Kang, et al.
Circulation. Heart Failure|October 30, 2019
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical CenterLauren A Eberly, Aaron Richterman, Anne G Beckett, et al.
Pageof 8